Posterior reversible encephalopathy syndrome after intravitreal bevacizumab injection in patient with choroidal neovascular membrane secondary to age-related maculopathy


ARTUNAY H. Ö., Yuzbasioglu E., Rasier R., Sengul A., Bahcecioglu H.

Journal of Ocular Pharmacology and Therapeutics, cilt.26, sa.3, ss.301-303, 2010 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 3
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1089/jop.2009.0148
  • Dergi Adı: Journal of Ocular Pharmacology and Therapeutics
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.301-303
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

The posterior reversible encephalopathy syndrome (PRES), a complex of cerebral disorders including headache, seizures, visual disturbances, is associated with a variety of conditions in which blood pressure rises acutely. Arterial hypertension can occur in systemic administration of bevacizumab. A few cases of systemic injection of bevazicumab-induced PRES have been reported. In this article, we first report on a patient who developed PRES following intravitreal bevazicumab. © 2010, Mary Ann Liebert, Inc.